TransScan expands chairman Kirshner’s duties

Article

Breast imaging device developer TransScan of Ramsey, NJ, has expanded chairman Hal Kirshner’s duties to include those of president and CEO. Kirshner joined TransScan in May 1999. Before that he had served as president and CEO of Trex Medical and

Breast imaging device developer TransScan of Ramsey, NJ, has expanded chairman Hal Kirshner’s duties to include those of president and CEO. Kirshner joined TransScan in May 1999. Before that he had served as president and CEO of Trex Medical and president of Trex subsidiary Lorad (SCAN 5/12/99).

Under Kirshner’s chairmanship, TransScan received premarket approval clearance from the Food and Drug Administration for improvements in the design and operation of its TS-2000 electrical impedance breast scanning system (SCAN 11/24/99). The FDA initially cleared the unit last April for use as an adjunct to mammography for follow-up exams in patients with equivocal mammograms.

Recent Videos
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Related Content
© 2025 MJH Life Sciences

All rights reserved.